loader from loading.io

Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers

Walking the Genetic Line

Release Date: 11/27/2025

Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms show art Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms

Walking the Genetic Line

Guest: Ali Hall Theme: Queer Identity, Bodily Autonomy, and the BRCA Diagnosis Nobody Saw Coming Episode Summary When Ali Hall stole a 23andMe kit from a family white elephant exchange, she wasn't looking for anything life-changing. Five years later, an email arrived while she was picking her kid up from school: her results had been updated. She had a BRCA mutation. What followed wasn't panic — and that itself is the story. Ali's response was shaped by something older than the diagnosis: a lifelong pattern of minimizing her own experience when people around her were...

info_outline Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy show art Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy

Walking the Genetic Line

Episode Summary Jennifer never knew her biological father growing up — and when she finally let him back into her life at 25, what he brought with him was a medical history that would change everything. Phone call after phone call, a new cancer. Eight-plus organ cancers. Over a hundred skin cancers. Years before anyone thought to offer him a genetic test. When Lynch Syndrome MSH2 was finally identified, Jennifer wasn't ready — she was a single mother, financially stretched, emotionally guarded, and carrying decades of unresolved grief toward a man who had never shown up for her. She put...

info_outline Solo Episode: Living with Hereditary Cancer and Risk in a Loud World show art Solo Episode: Living with Hereditary Cancer and Risk in a Loud World

Walking the Genetic Line

Host: Sara Champie, LCSW Theme: Navigating medical vulnerability, global instability, and nervous system overwhelm during hereditary cancer risk and treatment. Episode summary What happens when your body is healing, your life is medically uncertain, and the world around you feels like it’s unraveling? In this solo episode, therapist Sara Champie explores a reality many people navigating hereditary cancer risk quietly experience: the nervous system strain of managing personal medical vulnerability while absorbing the constant noise of global crisis. When surgery, treatment, or high-stakes...

info_outline Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery show art Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery

Walking the Genetic Line

Guest: Katie McMurray Theme: BRCA1, sisterhood, developmental trauma, and choosing preventative surgery in young adulthood Episode summary When Katie was 17, she lost her mother to breast cancer. Years later, genetic testing confirmed what she had long suspected: she carries a BRCA1 mutation. In this episode, Katie and Sara Champie explore what happens when grief resurfaces through genetic testing — how identity shifts, how fear and agency intertwine, and how the loss of a parent shapes medical decision-making. At 25, during the height of COVID, Katie chose preventative mastectomy surgery....

info_outline Ingrid Nishimoto, LCSW: Peutz-Jeghers Syndrome and Intergenerational Emotional Inheritance show art Ingrid Nishimoto, LCSW: Peutz-Jeghers Syndrome and Intergenerational Emotional Inheritance

Walking the Genetic Line

Guest: Ingrid Nishimoto, LCSW Theme: Inherited Narratives—Moving Beyond the Parent’s Story to Claim Your Own Episode Summary When Ingrid Nishimoto was diagnosed with Peutz-Jeghers Syndrome at age 17, she wasn't just handed a medical management plan; she was handed a mirror of her father’s life and early death. In this profound conversation with Sara Champie, LCSW, Ingrid explores the "Time Collapse" that occurs when a genetic diagnosis makes the past and future converge in the present. As a fellow psychotherapist, Ingrid deconstructs the emotional burden of living past the age a parent...

info_outline Sara Kavanaugh: From Health Anxiety to Empowerment—Transforming Hereditary Cancer Risk into Healing show art Sara Kavanaugh: From Health Anxiety to Empowerment—Transforming Hereditary Cancer Risk into Healing

Walking the Genetic Line

Guest: Sara Kavanaugh Theme: Living as a Previvor—Agency, Advocacy, and Reframing Anxiety After Genetic Testing Episode summary When Sara Kavanaugh learned she carried mutations in her MSH6 (Lynch syndrome) and Check2 genes, she moved from decades of health anxiety—and ambiguous uncertainty—to a new sense of empowerment and structure. In this dialogue with psychotherapist and fellow traveler Sara Champie, Sara shares how learning her genetic status fundamentally changed her identity, led her to fierce self-advocacy, and inspired her to create the Positive Gene Podcast—a resource and...

info_outline Sara Kourouma: From Childhood Loss to Empowerment, Creating Community for BRCA Carriers show art Sara Kourouma: From Childhood Loss to Empowerment, Creating Community for BRCA Carriers

Walking the Genetic Line

Guest: Sara Kourouma Theme: Loss, agency, and community—the emotional journey of living with BRCA2 Episode summary When Sara Kourouma discovered she carried the BRCA2 mutation as a young adult—after losing her mother to breast cancer at age 10—she was thrust into a landscape defined by uncertainty, risk, and the weight of generational loss. In this episode, Sara Champie sits down with Sara Kourouma, a clinical social worker serving New York and Texas, to explore how privilege, access, grief, and human connection have shaped her journey through surveillance, multiple prophylactic...

info_outline Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis show art Beth Martinetti: Family, Fertility, and Identity after Hereditary Cancer Diagnosis

Walking the Genetic Line

Episode Summary When Beth Martinetti—Pilates instructor, mother of three, and lifelong student of her own body—discovered multiple genetic mutations at 45, it was the latest chapter in a lifetime shaped by both visible and invisible challenges. Beth shares her journey from adolescent injury and Ehlers-Danlos diagnosis, through complicated pregnancies, to a midlife cascade: mysterious symptoms, pivotal encounters with validating doctors, and ultimately, the discovery that she carries BRCA1, CHEK2, and a variant in BARD1. Still in the thick of surgical recovery, Beth invites us into her...

info_outline Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers show art Dr. Corinne Menn: The Truth About Hormone Replacement for BRCA Carriers and Previvers

Walking the Genetic Line

Guest: Dr. Corinne Menn Theme: Claiming agency in hereditary cancer risk, surgical menopause, and a new era of HRT care Episode summary When Dr. Corinne Menn—board certified OB/GYN, Menopause Society certified practitioner, 23+ year breast cancer survivor, and BRCA2 carrier—joins us, she brings unparalleled lived and clinical expertise to walking the genetic line. In this conversation, Dr. Corinne Menn shares her deeply personal journey: breast cancer at 28, the loss of her mother to ovarian cancer, and the years navigating her own genetic risk and premature menopause. Together, we...

info_outline Martha Kaiser: From Melanoma Diagnosis to Genetic Discovery – A Journey of Agency and Ancestry show art Martha Kaiser: From Melanoma Diagnosis to Genetic Discovery – A Journey of Agency and Ancestry

Walking the Genetic Line

Guest: Martha Kaiser Theme: Walking with CDKN2A, Ancestral Discovery, and Agency in Rare Genetic Mutations Episode Summary When Martha Kaiser discovered she carries the rare CDKN2A gene mutation—known for elevating risks of melanoma and pancreatic cancer—her journey shifted from uncertainty, loss, and family trauma to active agency and deep exploration. In this conversation, she shares not only the medical dimensions of living with a lesser-known mutation, but how intergenerational silence, gut intuition, and the drive to protect her children led her to become both a patient advocate and a...

info_outline
 
More Episodes

Guest: Dr. Corinne Menn
Theme: Claiming agency in hereditary cancer risk, surgical menopause, and a new era of HRT care

Episode summary
When Dr. Corinne Menn—board certified OB/GYN, Menopause Society certified practitioner, 23+ year breast cancer survivor, and BRCA2 carrier—joins us, she brings unparalleled lived and clinical expertise to walking the genetic line. In this conversation, Dr. Corinne Menn shares her deeply personal journey: breast cancer at 28, the loss of her mother to ovarian cancer, and the years navigating her own genetic risk and premature menopause. Together, we explore why BRCA (and other mutation) “previvors” often land in a black hole of care, how miscommunication and provider fear still undermine evidence-based treatment, and the hopeful shift as new guidelines and cultural change begin to reshape what’s possible for those living at hereditary risk.

We cover

  • Dr. Corinne Menn

    ’s origin story: the collision of residency, a breast cancer diagnosis in her 20s, and her mother’s ovarian cancer and loss

  • How outdated genetic testing, medical gaslighting, and trauma shaped her assertiveness as both patient and physician

  • The “CEO of your health” mindset: building self-trust and voice inside overwhelming medical realities

  • The giant gap in menopause and HRT education across the entire medical field (~20 years of misinformation and fear after the WHI study)

  • What most doctors STILL get wrong about HRT for BRCA carriers—and how new FDA changes and Menopause Society guidelines support safer, more nuanced use

  • Proactive care: why pre-surgery counseling and immediate access to HRT matter for quality of life, bone, heart, and brain health

  • “Female castration”—naming the reality and impact of surgical menopause and how it’s minimized systemically

  • How trauma-informed therapy and a more holistic approach are essential for hereditary cancer communities and all patients in medical systems

Highlights & takeaways

  • “All BRCA previvors must demand pre-op counseling and a pre-op management plan on how their doctor is going to manage their abrupt surgical menopause. This is not optional.”

  • The harm of not providing HRT after surgical menopause is severe: double the risk of heart disease, dementia, osteoporosis, mood disorders—especially for those under 45.

  • New FDA changes (Spring 2024): the black box warning on estrogen is being removed/updated, allowing for clearer, less fear-based counseling about HRT’s risks and benefits.

  • For BRCA (and other mutation) carriers, HRT up to natural menopause is standard of care. The fear of HRT, especially after risk-reducing surgeries, is both outdated and damaging.

  • Genitourinary syndrome of menopause deserves more attention and treatment—local vaginal estrogen is safe, effective, and newly destigmatized.

  • “If you wouldn't tell a man at 31 who lost his testicles to just try coconut oil—don't do that to female patients after oophorectomy.”

Content note
Includes discussion of parental death, breast/ovarian cancer, early menopause, medical trauma, sexual health, and systemic gaps in care.

Resources mentioned & organizations

Connect

If this episode resonated, please follow, rate, and share.
Find Sara on IG/TikTok @FaceTheRiskTogether and get free tools, group support, and offerings at the link in bio.
You’re not alone—we can walk this line together.